Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocular Therapeutix

7.31
+0.14001.95%
Post-market: 7.310.00000.00%19:57 EDT
Volume:1.63M
Turnover:11.85M
Market Cap:1.16B
PE:-5.98
High:7.38
Open:7.16
Low:7.12
Close:7.17
Loading ...
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 25, 2024

Major Issues Report

Form 8-K - Current report
Dec 29, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Correspondence

Form CORRESP - Correspondence
Nov 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 04, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2023

Major Issues Report

Form 8-K - Current report
Sep 13, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2023

Major Issues Report

Form 8-K - Current report